Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0021051 (
immunodeficiency
)
71,517
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The
Rex
protein of the human T-cell leukemia virus type II (HTLV-II),
Rex
-II, plays a central role in regulating the expression of the structural genes of this retrovirus.
Rex
-II acts posttranscriptionally by inducing the cytoplasmic expression of the incompletely spliced viral mRNAs that encode the Gag and Env structural proteins and the enzymes derived from the pol gene. We now define a 295-nucleotide cis-acting regulatory element within the 3' long terminal repeat of HTLV-II that is required for the effects of
Rex
-II. This
Rex
-II response element (RexIIRE) corresponds to a predicted, highly stable RNA secondary structure and functions when present in the sense but not in the antisense orientation. The RexIIRE confers responsiveness not only to
Rex
-II but also to the
Rex
protein of HTLV-I. Deletion and substitution mutagenesis of the RexIIRE permitted identification of a small subregion within the larger element critically required for
Rex
-II responsiveness and further suggested that the structurally distinct RexIIREs generated from the 5' and 3' long terminal repeats of HTLV-II may differentially regulate the cytoplasmic expression of unspliced gag-pol and singly spliced env mRNAs. While the Rev protein of human
immunodeficiency
virus type 1 fails to function via the RexIIRE, the
Rex
-II protein, like
Rex
-I, can functionally replace the Rev protein of human
immunodeficiency
virus type 1 via its interaction with the Rev response element (RevRE).
...
PMID:Rex transregulation of human T-cell leukemia virus type II gene expression. 198 5
Human T-cell leukemia virus type I (HTLV-I) encodes a 27-kDa trans-acting gene product (
Rex
) which is involved in the regulated expression of transcripts coding for the viral structural proteins. We used oligonucleotide-directed mutagenesis to generate a series of mutant HTLV-I rex genes. Transient expression experiments demonstrated that 3 of 28 mutant proteins are functionally inactive on the homologous HTLV-I rex response element, whereas an additional 2 mutant proteins are functionally inactive on the heterologous human
immunodeficiency
virus type 1 rev response element. One of these mutants is able to suppress the function of the wild-type HTLV-I
Rex
protein in trans on the homologous rex response element sequence. Furthermore, all of these mutants are able to inhibit
Rex
function on the heterologous rev response element sequence. Intriguingly, only three of these mutants are able to inhibit the human
immunodeficiency
virus type 1 Rev protein in a dominant-negative manner.
...
PMID:Transdominant repressors for human T-cell leukemia virus type I rex and human immunodeficiency virus type 1 rev function. 198 19
The human T-cell leukemia viruses (HTLVs) encode a trans-regulatory protein,
Rex
, which differentially regulates viral gene expression by controlling the cytoplasmic accumulation of viral mRNAs. Because of insufficient amounts of purified protein, biochemical characterization of
Rex
activity has not previously been performed. Here, utilizing the baculovirus expression system, we purified HTLV type II (HTLV-II)
Rex
from the cytoplasmic fraction of recombinant baculovirus-infected insect cells by heparin-agarose chromatography. We directly demonstrated that
Rex
specifically bound HTLV-II 5' long terminal repeat RNA in both gel mobility shift and immunobinding assays. Sequences sufficient for
Rex
binding were localized to the R-U5 region of the HTLV-II 5' long terminal repeat and correlate with the region required for
Rex
function. The human
immunodeficiency
virus type 1 (HIV-1), has an analogous regulatory protein, Rev, which directly binds to and mediates its action through the Rev-responsive element located within the HIV-1 env gene. We demonstrated that HTLV-II
Rex
rescued an HIV-1JR-CSF Rev-deficient mutant, although inefficiently. This result is consistent with a weak binding activity to the HIV-1 Rev-responsive element under conditions in which it efficiently bound the HTLV-II long terminal repeat RNA.
...
PMID:Human T-cell leukemia virus (HTLV) type II Rex protein binds specifically to RNA sequences of the HTLV long terminal repeat but poorly to the human immunodeficiency virus type 1 Rev-responsive element. 201 58
Two chimeric mutant genes derived from rev of human
immunodeficiency
virus type 1 and rex of human T-cell leukemia virus type I were constructed to investigate the functions of the nucleolar-targeting signals (NOS) in Rev and
Rex
proteins. A chimeric
Rex
protein whose NOS region was substituted with the NOS of Rev was located predominantly in the cell nucleolus and functioned like the wild-type protein in the
Rex
assay system. However, a chimeric Rev with the NOS of
Rex
abolished Rev function despite its nucleolar localization. This nonfunctional nucleolar-targeting chimeric protein inhibited the function of both
Rex
and Rev. In the same experimental conditions, this mutant interfered with the localization of the functional
Rex
in the nucleolus.
...
PMID:Effects of chimeric mutants of human immunodeficiency virus type 1 Rev and human T-cell leukemia virus type I Rex on nucleolar targeting signals. 201 67
Expression of the human T-cell leukemia virus type I (HTLV-I) rex gene is a prerequisite for the expression of the retroviral structural proteins. We have generated internal deletion mutants of this 27-kDa nucleolar trans-acting gene product to define functional domains in the
Rex
protein. The phenotype of the various mutant proteins was tested on the homologous HTLV-I rex response element sequence and the heterologous human
immunodeficiency
virus type 1 (HIV-1) rev response element sequence. Our results indicate that a region between amino acid residues 55 and 132 in the 189-amino-acid
Rex
protein is required for
Rex
-mediated trans activation on both retroviral response element sequences. In addition, substitution of the
Rex
nuclear localization signal by a sequence of the HIV-1 rev gene product targets the
Rex
protein to the correct subcellular compartment required for
Rex
function.
...
PMID:Mutational analysis of the human T-cell leukemia virus type I trans-acting rex gene product. 203 76
The binding of Rev protein of human
immunodeficiency
virus type 1 (HIV-1) to the cis-acting Rev-responsive element (RRE) was compared to the binding of a trans-dominant Rev mutant. RevBL, which inhibits Rev function. Rev and RevBL expressed in bacteria were purified and shown to bind in vitro to the RRE with similar affinities. The study of the RRE mutants indicated that Rev and RevBL bind to the same target within the RRE in vitro and in vivo. In vivo experiments demonstrated that RevBL did not increase the steady-state levels of HIV-1 mRNA or protein. These experiments suggested that additional cellular factors interacting with Rev but not with RevBL are necessary for function. The
Rex
protein of human T-cell leukemia virus type I (HTLV-I) is similar to Rev and acts through a sequence named
Rex
-responsive element (RXRE) located in the long terminal repeat of HTLV-I. We examined the function of RevBL on a hybrid mRNA molecule containing both the RRE and RXRE. While RevBL prevented Rev function, it did not affect
Rex
function on the mRNA containing either the RXRE or both the RRE and RXRE. Therefore, binding of RevBL to the RRE had neither positive nor negative effects on the mRNA, since this mRNA could be efficiently utilized in the presence of a functional
Rex
-RXRE interaction. The results obtained in vivo and in vitro strongly suggest that RevBL inhibits Rev function by binding to the same site as Rev and preventing Rev binding and function.
...
PMID:Binding of trans-dominant mutant Rev protein of human immunodeficiency virus type 1 to the cis-acting Rev-responsive element does not affect the fate of viral mRNA. 208 1
The ability of the
Rex
protein of the type I human T-cell leukemia virus (HTLV-I) to regulate expression of the retroviral gag and env structural genes post-transcriptionally is critically dependent on the presence of a
Rex
response element (RexRE). This cis-regulatory sequence is located within the retroviral 3' long terminal repeat and coincides with a predicted, highly stable RNA stem-loop structure.
Rex
action requires both the overall secondary structure intrinsic to the RexRE and specific sequences from one small subregion of this large structure. This small subregion likely forms a protein-binding site for
Rex
or a cellular RNA-binding factor. Whereas
Rex
can functionally replace the Rev protein of the type 1 human
immunodeficiency
virus (HIV-1) through its interaction with the analogous Rev response element (RevRE), distinct subregions of this HIV-1 RNA element mediate the responses to
Rex
and Rev. Strikingly,
Rex
acts as a dominant repressor of Rev action, following the deletion of the
Rex
responsive subregion of the RevRE. Similarly, Rev inhibits
Rex
function in a dominant manner when the Rev responsive subregion of the RevRE is deleted. Together, these findings suggest that
Rex
and Rev not only interact with their respective RNA response elements but also may either form mixed inactive multimers or interact with a common cellular factor(s). If binding of a common host protein is involved, this factor likely plays a central role either in spliceosome assembly or nuclear RNA transport.
...
PMID:Structure-function analyses of the HTLV-I Rex and HIV-1 Rev RNA response elements: insights into the mechanism of Rex and Rev action. 211 86
Visna virus is an ungulate lentivirus that is distantly related to the primate lentiviruses, including human
immunodeficiency
virus type 1 (HIV-1). Replication of HIV-1 and of other complex primate retroviruses, including human T-cell leukemia virus type I (HTLV-I), requires the expression in trans of a virally encoded post-transcriptional activator of viral structural gene expression termed Rev (HIV-1) or
Rex
(HTLV-I). We demonstrate that the previously defined L open reading frame of visna virus encodes a protein, here termed Rev-V, that is required for the cytoplasmic expression of the incompletely spliced RNA that encodes the viral envelope protein. Transactivation by Rev-V was shown to require a cis-acting target sequence that coincides with a predicted RNA secondary structure located within the visna virus env gene. However, Rev-V was unable to function by using the structurally similar RNA target sequences previously defined for Rev or
Rex
and, therefore, displays a distinct sequence specificity. Remarkably, substitution of this visna virus target sequence in place of the HIV-1 Rev response element permitted the Rev-V protein to efficiently rescue the expression of HIV-1 structural proteins, including Gag, from a Rev- proviral clone. These results suggest that the post-transcriptional regulation of viral structural gene expression may be a characteristic feature of complex retroviruses.
...
PMID:Visna virus encodes a post-transcriptional regulator of viral structural gene expression. 217 Sep 81
The interaction of the human
immunodeficiency
virus type 1 (HIV-1) Rev protein with a structured region in env mRNA (the Rev-responsive element [RRE]) mediates the export of structural mRNAs from the nucleus to the cytoplasm. We demonstrated that unlike HIV-1 Rev, which functions with both the HIV-1 and HIV-2 RREs, HIV-2 Rev functions only with the HIV-2 RRE. Rev-RRE binding studies suggested that the lack of nonreciprocal complementation stems from the inability of HIV-2 Rev to interact with HIV-1 RRE RNA. Maintenance of RNA secondary structure, rather than the primary nucleotide sequence, appeared to be the major determinant for interaction of both HIV-1 and HIV-2 Rev with the HIV-2 RRE. Moreover, the binding domain of the HIV-2 RRE recognized by HIV-1 Rev was dissimilar to the binding domain of the HIV-1 RRE, in terms of both secondary structure and primary nucleotide sequence. Our results support the hypothesis that function of HIV Rev proteins and possibly the functionally similar
Rex
proteins encoded by the human T-cell leukemia viruses (HTLVs) HTLV-I and HTLV-II is controlled by the presence of RNA secondary structure generated within the RRE RNA.
...
PMID:Function of the human immunodeficiency virus types 1 and 2 Rev proteins is dependent on their ability to interact with a structured region present in env gene mRNA. 220 Aug 88
We have analyzed the action of the Rev and Tev proteins of human
immunodeficiency
virus type 1 (HIV-1) and of the
Rex
protein of human T-cell leukemia virus type I (HTLV-I) on a series of Rev-responsive element (RRE) mutants. The minimum continuous RRE region necessary and sufficient for Rev function was determined to be 204 nucleotides. Interestingly, this region was not sufficient for Tev or
Rex
function. These proteins require additional sequences, which may stabilize the structure of the RRE or may contain additional sequence-specific elements. Internal RRE deletions revealed that the targets for Rev and
Rex
can be separated, since mutants responding to Rev and not
Rex
and vice versa were identified. Tev was active on both types of mutants, suggesting that it has a more relaxed specificity than do both Rev and
Rex
proteins. Although Rev and
Rex
targets within the RRE appear to be distinct, the trans-dominant mutant RevBL prevents the RRE interaction with
Rex
. RevBL cannot inhibit the function of
Rex
on RRE deletions that lack the Rev-responsive portion. These results indicate the presence of distinct sites within the RRE for interaction with these proteins. The binding sites for the different proteins do not function independently and may interfere with one another. Mutations affecting the RRE may change the accessibility and binding characteristics of the different binding sites.
...
PMID:Different sites of interaction for Rev, Tev, and Rex proteins within the Rev-responsive element of human immunodeficiency virus type 1. 224 84
<< Previous
1
2
3
4
5
6
Next >>